中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
3期
86-87,88
,共3页
荆花胃康胶丸%糜烂型胃炎%标准三联
荊花胃康膠汍%糜爛型胃炎%標準三聯
형화위강효환%미란형위염%표준삼련
Jinghuaweikang capsules%Erosive gastritis%Standard triple
目的：探讨荆花胃康胶丸联合标准三联疗法治疗糜烂型胃炎愈合及改善情况。方法：连续收集慢性糜烂型胃炎患者50例纳入临床观察，按照随机数字表法分治疗组和观察组，每组25例。治疗组用荆花胃康胶丸加标准三联疗法，对照组只用三联疗法。分别于治疗第2、3、4周观察临床症状改善情况及治疗前后胃镜下胃炎愈合情况。结果：经过4周治疗，治疗组临床症状改善总有效率为92%，对照组为60%，两组比较差异有统计学意义（P<0.05）。治疗结束后，治疗组胃镜下黏膜糜烂愈合总有效率为92%，对照组为56%，两组比较差异有统计学意义（P<0.05）。两组均未见明显副作用。结论：荆花胃康胶丸联合标准三联疗法有利于慢性糜烂型胃炎黏膜糜烂的愈合及症状的改善。
目的：探討荊花胃康膠汍聯閤標準三聯療法治療糜爛型胃炎愈閤及改善情況。方法：連續收集慢性糜爛型胃炎患者50例納入臨床觀察，按照隨機數字錶法分治療組和觀察組，每組25例。治療組用荊花胃康膠汍加標準三聯療法，對照組隻用三聯療法。分彆于治療第2、3、4週觀察臨床癥狀改善情況及治療前後胃鏡下胃炎愈閤情況。結果：經過4週治療，治療組臨床癥狀改善總有效率為92%，對照組為60%，兩組比較差異有統計學意義（P<0.05）。治療結束後，治療組胃鏡下黏膜糜爛愈閤總有效率為92%，對照組為56%，兩組比較差異有統計學意義（P<0.05）。兩組均未見明顯副作用。結論：荊花胃康膠汍聯閤標準三聯療法有利于慢性糜爛型胃炎黏膜糜爛的愈閤及癥狀的改善。
목적：탐토형화위강효환연합표준삼련요법치료미란형위염유합급개선정황。방법：련속수집만성미란형위염환자50례납입림상관찰，안조수궤수자표법분치료조화관찰조，매조25례。치료조용형화위강효환가표준삼련요법，대조조지용삼련요법。분별우치료제2、3、4주관찰림상증상개선정황급치료전후위경하위염유합정황。결과：경과4주치료，치료조림상증상개선총유효솔위92%，대조조위60%，량조비교차이유통계학의의（P<0.05）。치료결속후，치료조위경하점막미란유합총유효솔위92%，대조조위56%，량조비교차이유통계학의의（P<0.05）。량조균미견명현부작용。결론：형화위강효환연합표준삼련요법유리우만성미란형위염점막미란적유합급증상적개선。
Objective:To explore the efficacy of jinghuaweikang capsules with standard triple therapy in the treatment of the chronic erosive gastritis and to improve the healing quality of erosion.Method:Fifty patients with chronic erosive gastritis were randomly and equally divided into two groups,each group of 25 cases. The control group was treated with standard triple and the therapy group was treated with jinghuaweikang capsules plus standard triple. Both groups were successive treated for 4 weeks .The symptoms were assessed before and 2,3,4 weeks after the treatment,as well as the endoscopic examination were conducted before and after the treatment.Result:The total remission rate of symptoms of the control group was 60%while the therapy group was 92%after treatment,and the difference between the difference was statistically significant(P<0.05). In addition the recovery rate of mucosal erosion in the control group was 56%and it was 92%in the therapy group,and the difference between the two groups was statistically significant (P<0.05).The side effects were not found in both groups.Conclusion:Jinghuaweikang capsules plus standard triple is beneficial for recovery of erosive gastric mucosa and improvement of dyspepsia symptoms.
